Study of DSP-7888 in Patients With Myelodysplastic Syndrome
Clinical trial NCT02436252 · COMPLETED
Trial details
- NCT number
- NCT02436252
- Sponsor
- Sumitomo Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2020-03-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.